These are some of the clinical trials open at Rush for rheumatology disorders. To inquire about other similar studies that may be open to enrollment, call (312) 942-2167.
Gout and Significant Cardiovascular Comorbidities Study: This is a Phase 3 study designed to evaluate the cardiovascular safety of the study medication compared to allopurinol in subjects with gout and significant cardiovascular comorbidities.
Knee Osteoarthritis Medication Study: A Phase 3 study to evaluate the safety and effectiveness of the study medication in the treatment of osteoarthritis of the knee
Moderate to Severe Systemic Lupus Erythematosus Study: A Phase 3, randomized, double-blind placebo-controlled study testing the efficacy and safety of a medication in subjects with moderate to severe SLE (systemic lupus erythematosus)